Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets
Large linked healthcare administrative datasets could be used to monitor programs providing prevention and treatment services to people who inject drugs (PWID). However, diagnostic codes in administrative datasets do not differentiate non-injection from injection drug use (IDU). We validated algorit...
Gespeichert in:
Veröffentlicht in: | The International journal of drug policy 2018-05, Vol.55, p.31-39 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 39 |
---|---|
container_issue | |
container_start_page | 31 |
container_title | The International journal of drug policy |
container_volume | 55 |
creator | Janjua, Naveed Zafar Islam, Nazrul Kuo, Margot Yu, Amanda Wong, Stanley Butt, Zahid A. Gilbert, Mark Buxton, Jane Chapinal, Nuria Samji, Hasina Chong, Mei Alvarez, Maria Wong, Jason Tyndall, Mark W. Krajden, Mel |
description | Large linked healthcare administrative datasets could be used to monitor programs providing prevention and treatment services to people who inject drugs (PWID). However, diagnostic codes in administrative datasets do not differentiate non-injection from injection drug use (IDU). We validated algorithms based on diagnostic codes and prescription records representing IDU in administrative datasets against interview-based IDU data.
The British Columbia Hepatitis Testers Cohort (BC-HTC) includes ∼1.7 million individuals tested for HCV/HIV or reported HBV/HCV/HIV/tuberculosis cases in BC from 1990 to 2015, linked to administrative datasets including physician visit, hospitalization and prescription drug records. IDU, assessed through interviews as part of enhanced surveillance at the time of HIV or HCV/HBV diagnosis from a subset of cases included in the BC-HTC (n = 6559), was used as the gold standard. ICD-9/ICD-10 codes for IDU and injecting-related infections (IRI) were grouped with records of opioid substitution therapy (OST) into multiple IDU algorithms in administrative datasets. We assessed the performance of IDU algorithms through calculation of sensitivity, specificity, positive predictive, and negative predictive values.
Sensitivity was highest (90–94%), and specificity was lowest (42–73%) for algorithms based either on IDU or IRI and drug misuse codes. Algorithms requiring both drug misuse and IRI had lower sensitivity (57–60%) and higher specificity (90–92%). An optimal sensitivity and specificity combination was found with two medical visits or a single hospitalization for injectable drugs with (83%/82%) and without OST (78%/83%), respectively. Based on algorithms that included two medical visits, a single hospitalization or OST records, there were 41,358 (1.2% of 11–65 years individuals in BC) recent PWID in BC based on health encounters during 3- year period (2013–2015).
Algorithms for identifying PWID using diagnostic codes in linked administrative data could be used for tracking the progress of programing aimed at PWID. With population-based datasets, this tool can be used to inform much needed estimates of PWID population size. |
doi_str_mv | 10.1016/j.drugpo.2018.02.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2008892129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0955395918300306</els_id><sourcerecordid>2089865936</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-5cdc736086b9538c8ae8088df6739ebabb17c7116bf3eb7527179b45d3e036233</originalsourceid><addsrcrecordid>eNp9kT1v1TAYhS1ERS-Ff4CQJRaWpP6IE3tBQhUflSqxtLPl2G96HeXawU6KysY_x-m9MDAweXmeY_schN5QUlNC28uxdmm9n2PNCJU1YTUh9BnaUdnxqumEfI52RAlRcSXUOXqZ80gIaWhDX6BzphrJqCA79OvaQVj88OjDPfZhBLv4GPAWjdcM2ASHIS_-YJaNmOO8TuYJyf4n4DjgGeI8Af6xjyf_Sc7F3oQ9mGnZW5NKlDv44POSiv8A2JnFZFjyK3Q2mCnD69N5ge4-f7q9-lrdfPtyffXxprINbZdKWGc73hLZ9kpwaaUBSaR0Q9txBb3pe9rZjtK2Hzj0nWAd7VTfCMeB8JZxfoHeH3PnFL-v5U_64LOFaTIB4po1IyVOMcpUQd_9g45xTaG8rlBSyVYo3haqOVI2xZwTDHpOpaf0qCnR20R61MeJ9DaRJkyXiYr29hS-9gdwf6U_mxTgwxGA0saDh6Sz9RAsOJ9KvdpF__8bfgO5PaZw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2089865936</pqid></control><display><type>article</type><title>Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Elsevier ScienceDirect Journals Complete</source><source>PAIS Index</source><creator>Janjua, Naveed Zafar ; Islam, Nazrul ; Kuo, Margot ; Yu, Amanda ; Wong, Stanley ; Butt, Zahid A. ; Gilbert, Mark ; Buxton, Jane ; Chapinal, Nuria ; Samji, Hasina ; Chong, Mei ; Alvarez, Maria ; Wong, Jason ; Tyndall, Mark W. ; Krajden, Mel</creator><creatorcontrib>Janjua, Naveed Zafar ; Islam, Nazrul ; Kuo, Margot ; Yu, Amanda ; Wong, Stanley ; Butt, Zahid A. ; Gilbert, Mark ; Buxton, Jane ; Chapinal, Nuria ; Samji, Hasina ; Chong, Mei ; Alvarez, Maria ; Wong, Jason ; Tyndall, Mark W. ; Krajden, Mel ; for the BC Hepatitis Testers Cohort Team ; BC Hepatitis Testers Cohort Team</creatorcontrib><description>Large linked healthcare administrative datasets could be used to monitor programs providing prevention and treatment services to people who inject drugs (PWID). However, diagnostic codes in administrative datasets do not differentiate non-injection from injection drug use (IDU). We validated algorithms based on diagnostic codes and prescription records representing IDU in administrative datasets against interview-based IDU data.
The British Columbia Hepatitis Testers Cohort (BC-HTC) includes ∼1.7 million individuals tested for HCV/HIV or reported HBV/HCV/HIV/tuberculosis cases in BC from 1990 to 2015, linked to administrative datasets including physician visit, hospitalization and prescription drug records. IDU, assessed through interviews as part of enhanced surveillance at the time of HIV or HCV/HBV diagnosis from a subset of cases included in the BC-HTC (n = 6559), was used as the gold standard. ICD-9/ICD-10 codes for IDU and injecting-related infections (IRI) were grouped with records of opioid substitution therapy (OST) into multiple IDU algorithms in administrative datasets. We assessed the performance of IDU algorithms through calculation of sensitivity, specificity, positive predictive, and negative predictive values.
Sensitivity was highest (90–94%), and specificity was lowest (42–73%) for algorithms based either on IDU or IRI and drug misuse codes. Algorithms requiring both drug misuse and IRI had lower sensitivity (57–60%) and higher specificity (90–92%). An optimal sensitivity and specificity combination was found with two medical visits or a single hospitalization for injectable drugs with (83%/82%) and without OST (78%/83%), respectively. Based on algorithms that included two medical visits, a single hospitalization or OST records, there were 41,358 (1.2% of 11–65 years individuals in BC) recent PWID in BC based on health encounters during 3- year period (2013–2015).
Algorithms for identifying PWID using diagnostic codes in linked administrative data could be used for tracking the progress of programing aimed at PWID. With population-based datasets, this tool can be used to inform much needed estimates of PWID population size.</description><identifier>ISSN: 0955-3959</identifier><identifier>EISSN: 1873-4758</identifier><identifier>DOI: 10.1016/j.drugpo.2018.02.001</identifier><identifier>PMID: 29482150</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Administrative data ; Algorithms ; Data analysis ; Drug abuse ; Drug administration ; Drug policy ; Drug use ; Drugs ; Health care ; Health services ; Hepatitis ; Hepatitis C ; HIV ; Hospitalization ; Human immunodeficiency virus ; Injection drug use ; Injections ; Medical databases ; Medical diagnosis ; Opioids ; People who inject drugs ; Population size estimates ; Prevention ; Prevention programs ; Substance abuse ; Surveillance ; Tracking ; Tuberculosis ; Values</subject><ispartof>The International journal of drug policy, 2018-05, Vol.55, p.31-39</ispartof><rights>2018 Elsevier B.V.</rights><rights>Copyright © 2018 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. May 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-5cdc736086b9538c8ae8088df6739ebabb17c7116bf3eb7527179b45d3e036233</citedby><cites>FETCH-LOGICAL-c416t-5cdc736086b9538c8ae8088df6739ebabb17c7116bf3eb7527179b45d3e036233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0955395918300306$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27843,27901,27902,30976,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29482150$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Janjua, Naveed Zafar</creatorcontrib><creatorcontrib>Islam, Nazrul</creatorcontrib><creatorcontrib>Kuo, Margot</creatorcontrib><creatorcontrib>Yu, Amanda</creatorcontrib><creatorcontrib>Wong, Stanley</creatorcontrib><creatorcontrib>Butt, Zahid A.</creatorcontrib><creatorcontrib>Gilbert, Mark</creatorcontrib><creatorcontrib>Buxton, Jane</creatorcontrib><creatorcontrib>Chapinal, Nuria</creatorcontrib><creatorcontrib>Samji, Hasina</creatorcontrib><creatorcontrib>Chong, Mei</creatorcontrib><creatorcontrib>Alvarez, Maria</creatorcontrib><creatorcontrib>Wong, Jason</creatorcontrib><creatorcontrib>Tyndall, Mark W.</creatorcontrib><creatorcontrib>Krajden, Mel</creatorcontrib><creatorcontrib>for the BC Hepatitis Testers Cohort Team</creatorcontrib><creatorcontrib>BC Hepatitis Testers Cohort Team</creatorcontrib><title>Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets</title><title>The International journal of drug policy</title><addtitle>Int J Drug Policy</addtitle><description>Large linked healthcare administrative datasets could be used to monitor programs providing prevention and treatment services to people who inject drugs (PWID). However, diagnostic codes in administrative datasets do not differentiate non-injection from injection drug use (IDU). We validated algorithms based on diagnostic codes and prescription records representing IDU in administrative datasets against interview-based IDU data.
The British Columbia Hepatitis Testers Cohort (BC-HTC) includes ∼1.7 million individuals tested for HCV/HIV or reported HBV/HCV/HIV/tuberculosis cases in BC from 1990 to 2015, linked to administrative datasets including physician visit, hospitalization and prescription drug records. IDU, assessed through interviews as part of enhanced surveillance at the time of HIV or HCV/HBV diagnosis from a subset of cases included in the BC-HTC (n = 6559), was used as the gold standard. ICD-9/ICD-10 codes for IDU and injecting-related infections (IRI) were grouped with records of opioid substitution therapy (OST) into multiple IDU algorithms in administrative datasets. We assessed the performance of IDU algorithms through calculation of sensitivity, specificity, positive predictive, and negative predictive values.
Sensitivity was highest (90–94%), and specificity was lowest (42–73%) for algorithms based either on IDU or IRI and drug misuse codes. Algorithms requiring both drug misuse and IRI had lower sensitivity (57–60%) and higher specificity (90–92%). An optimal sensitivity and specificity combination was found with two medical visits or a single hospitalization for injectable drugs with (83%/82%) and without OST (78%/83%), respectively. Based on algorithms that included two medical visits, a single hospitalization or OST records, there were 41,358 (1.2% of 11–65 years individuals in BC) recent PWID in BC based on health encounters during 3- year period (2013–2015).
Algorithms for identifying PWID using diagnostic codes in linked administrative data could be used for tracking the progress of programing aimed at PWID. With population-based datasets, this tool can be used to inform much needed estimates of PWID population size.</description><subject>Administrative data</subject><subject>Algorithms</subject><subject>Data analysis</subject><subject>Drug abuse</subject><subject>Drug administration</subject><subject>Drug policy</subject><subject>Drug use</subject><subject>Drugs</subject><subject>Health care</subject><subject>Health services</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>HIV</subject><subject>Hospitalization</subject><subject>Human immunodeficiency virus</subject><subject>Injection drug use</subject><subject>Injections</subject><subject>Medical databases</subject><subject>Medical diagnosis</subject><subject>Opioids</subject><subject>People who inject drugs</subject><subject>Population size estimates</subject><subject>Prevention</subject><subject>Prevention programs</subject><subject>Substance abuse</subject><subject>Surveillance</subject><subject>Tracking</subject><subject>Tuberculosis</subject><subject>Values</subject><issn>0955-3959</issn><issn>1873-4758</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>7TQ</sourceid><recordid>eNp9kT1v1TAYhS1ERS-Ff4CQJRaWpP6IE3tBQhUflSqxtLPl2G96HeXawU6KysY_x-m9MDAweXmeY_schN5QUlNC28uxdmm9n2PNCJU1YTUh9BnaUdnxqumEfI52RAlRcSXUOXqZ80gIaWhDX6BzphrJqCA79OvaQVj88OjDPfZhBLv4GPAWjdcM2ASHIS_-YJaNmOO8TuYJyf4n4DjgGeI8Af6xjyf_Sc7F3oQ9mGnZW5NKlDv44POSiv8A2JnFZFjyK3Q2mCnD69N5ge4-f7q9-lrdfPtyffXxprINbZdKWGc73hLZ9kpwaaUBSaR0Q9txBb3pe9rZjtK2Hzj0nWAd7VTfCMeB8JZxfoHeH3PnFL-v5U_64LOFaTIB4po1IyVOMcpUQd_9g45xTaG8rlBSyVYo3haqOVI2xZwTDHpOpaf0qCnR20R61MeJ9DaRJkyXiYr29hS-9gdwf6U_mxTgwxGA0saDh6Sz9RAsOJ9KvdpF__8bfgO5PaZw</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>Janjua, Naveed Zafar</creator><creator>Islam, Nazrul</creator><creator>Kuo, Margot</creator><creator>Yu, Amanda</creator><creator>Wong, Stanley</creator><creator>Butt, Zahid A.</creator><creator>Gilbert, Mark</creator><creator>Buxton, Jane</creator><creator>Chapinal, Nuria</creator><creator>Samji, Hasina</creator><creator>Chong, Mei</creator><creator>Alvarez, Maria</creator><creator>Wong, Jason</creator><creator>Tyndall, Mark W.</creator><creator>Krajden, Mel</creator><general>Elsevier B.V</general><general>Elsevier Science Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7TQ</scope><scope>8BJ</scope><scope>DHY</scope><scope>DON</scope><scope>FQK</scope><scope>JBE</scope><scope>7X8</scope></search><sort><creationdate>20180501</creationdate><title>Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets</title><author>Janjua, Naveed Zafar ; Islam, Nazrul ; Kuo, Margot ; Yu, Amanda ; Wong, Stanley ; Butt, Zahid A. ; Gilbert, Mark ; Buxton, Jane ; Chapinal, Nuria ; Samji, Hasina ; Chong, Mei ; Alvarez, Maria ; Wong, Jason ; Tyndall, Mark W. ; Krajden, Mel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-5cdc736086b9538c8ae8088df6739ebabb17c7116bf3eb7527179b45d3e036233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Administrative data</topic><topic>Algorithms</topic><topic>Data analysis</topic><topic>Drug abuse</topic><topic>Drug administration</topic><topic>Drug policy</topic><topic>Drug use</topic><topic>Drugs</topic><topic>Health care</topic><topic>Health services</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>HIV</topic><topic>Hospitalization</topic><topic>Human immunodeficiency virus</topic><topic>Injection drug use</topic><topic>Injections</topic><topic>Medical databases</topic><topic>Medical diagnosis</topic><topic>Opioids</topic><topic>People who inject drugs</topic><topic>Population size estimates</topic><topic>Prevention</topic><topic>Prevention programs</topic><topic>Substance abuse</topic><topic>Surveillance</topic><topic>Tracking</topic><topic>Tuberculosis</topic><topic>Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Janjua, Naveed Zafar</creatorcontrib><creatorcontrib>Islam, Nazrul</creatorcontrib><creatorcontrib>Kuo, Margot</creatorcontrib><creatorcontrib>Yu, Amanda</creatorcontrib><creatorcontrib>Wong, Stanley</creatorcontrib><creatorcontrib>Butt, Zahid A.</creatorcontrib><creatorcontrib>Gilbert, Mark</creatorcontrib><creatorcontrib>Buxton, Jane</creatorcontrib><creatorcontrib>Chapinal, Nuria</creatorcontrib><creatorcontrib>Samji, Hasina</creatorcontrib><creatorcontrib>Chong, Mei</creatorcontrib><creatorcontrib>Alvarez, Maria</creatorcontrib><creatorcontrib>Wong, Jason</creatorcontrib><creatorcontrib>Tyndall, Mark W.</creatorcontrib><creatorcontrib>Krajden, Mel</creatorcontrib><creatorcontrib>for the BC Hepatitis Testers Cohort Team</creatorcontrib><creatorcontrib>BC Hepatitis Testers Cohort Team</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>PAIS Index</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>MEDLINE - Academic</collection><jtitle>The International journal of drug policy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Janjua, Naveed Zafar</au><au>Islam, Nazrul</au><au>Kuo, Margot</au><au>Yu, Amanda</au><au>Wong, Stanley</au><au>Butt, Zahid A.</au><au>Gilbert, Mark</au><au>Buxton, Jane</au><au>Chapinal, Nuria</au><au>Samji, Hasina</au><au>Chong, Mei</au><au>Alvarez, Maria</au><au>Wong, Jason</au><au>Tyndall, Mark W.</au><au>Krajden, Mel</au><aucorp>for the BC Hepatitis Testers Cohort Team</aucorp><aucorp>BC Hepatitis Testers Cohort Team</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets</atitle><jtitle>The International journal of drug policy</jtitle><addtitle>Int J Drug Policy</addtitle><date>2018-05-01</date><risdate>2018</risdate><volume>55</volume><spage>31</spage><epage>39</epage><pages>31-39</pages><issn>0955-3959</issn><eissn>1873-4758</eissn><abstract>Large linked healthcare administrative datasets could be used to monitor programs providing prevention and treatment services to people who inject drugs (PWID). However, diagnostic codes in administrative datasets do not differentiate non-injection from injection drug use (IDU). We validated algorithms based on diagnostic codes and prescription records representing IDU in administrative datasets against interview-based IDU data.
The British Columbia Hepatitis Testers Cohort (BC-HTC) includes ∼1.7 million individuals tested for HCV/HIV or reported HBV/HCV/HIV/tuberculosis cases in BC from 1990 to 2015, linked to administrative datasets including physician visit, hospitalization and prescription drug records. IDU, assessed through interviews as part of enhanced surveillance at the time of HIV or HCV/HBV diagnosis from a subset of cases included in the BC-HTC (n = 6559), was used as the gold standard. ICD-9/ICD-10 codes for IDU and injecting-related infections (IRI) were grouped with records of opioid substitution therapy (OST) into multiple IDU algorithms in administrative datasets. We assessed the performance of IDU algorithms through calculation of sensitivity, specificity, positive predictive, and negative predictive values.
Sensitivity was highest (90–94%), and specificity was lowest (42–73%) for algorithms based either on IDU or IRI and drug misuse codes. Algorithms requiring both drug misuse and IRI had lower sensitivity (57–60%) and higher specificity (90–92%). An optimal sensitivity and specificity combination was found with two medical visits or a single hospitalization for injectable drugs with (83%/82%) and without OST (78%/83%), respectively. Based on algorithms that included two medical visits, a single hospitalization or OST records, there were 41,358 (1.2% of 11–65 years individuals in BC) recent PWID in BC based on health encounters during 3- year period (2013–2015).
Algorithms for identifying PWID using diagnostic codes in linked administrative data could be used for tracking the progress of programing aimed at PWID. With population-based datasets, this tool can be used to inform much needed estimates of PWID population size.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>29482150</pmid><doi>10.1016/j.drugpo.2018.02.001</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0955-3959 |
ispartof | The International journal of drug policy, 2018-05, Vol.55, p.31-39 |
issn | 0955-3959 1873-4758 |
language | eng |
recordid | cdi_proquest_miscellaneous_2008892129 |
source | Applied Social Sciences Index & Abstracts (ASSIA); Elsevier ScienceDirect Journals Complete; PAIS Index |
subjects | Administrative data Algorithms Data analysis Drug abuse Drug administration Drug policy Drug use Drugs Health care Health services Hepatitis Hepatitis C HIV Hospitalization Human immunodeficiency virus Injection drug use Injections Medical databases Medical diagnosis Opioids People who inject drugs Population size estimates Prevention Prevention programs Substance abuse Surveillance Tracking Tuberculosis Values |
title | Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T15%3A45%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identifying%20injection%20drug%20use%20and%20estimating%20population%20size%20of%20people%20who%20inject%20drugs%20using%20healthcare%20administrative%20datasets&rft.jtitle=The%20International%20journal%20of%20drug%20policy&rft.au=Janjua,%20Naveed%20Zafar&rft.aucorp=for%20the%20BC%20Hepatitis%20Testers%20Cohort%20Team&rft.date=2018-05-01&rft.volume=55&rft.spage=31&rft.epage=39&rft.pages=31-39&rft.issn=0955-3959&rft.eissn=1873-4758&rft_id=info:doi/10.1016/j.drugpo.2018.02.001&rft_dat=%3Cproquest_cross%3E2089865936%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2089865936&rft_id=info:pmid/29482150&rft_els_id=S0955395918300306&rfr_iscdi=true |